Patent: 9,822,158
✉ Email this page to a colleague
Summary for Patent: 9,822,158
Title: | Method for preparing crystalline insulin |
Abstract: | A method for crystallizing insulin or insulin analogs under alkaline conditions and purifying the insulin or insulin analog crystals by filtering through a filter and drying the insulin or insulin analog crystals captured on the filter to produce crystalline insulin or insulin analog crystal compositions is described. In particular aspects, the method may be used to crystalize insulin glargine. |
Inventor(s): | Ortigosa; Allison D. (Harrisonburg, VA), Perry; William (Longmont, CO), Sleevi; Mark C. (Longmont, CO), Sierra; Luis (Dunellen, NJ) |
Assignee: | Merck Sharp & Dohme Corp. (Rahway, NJ) |
Application Number: | 15/038,495 |
Patent Claims: | see list of patent claims |
Details for Patent 9,822,158
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 04/20/2000 | ⤷ Try a Trial | 2033-12-04 |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 04/25/2007 | ⤷ Try a Trial | 2033-12-04 |
Eli Lilly And Company | BASAGLAR | insulin glargine | Injection | 205692 | 12/16/2015 | ⤷ Try a Trial | 2033-12-04 |
Eli Lilly And Company | BASAGLAR | insulin glargine | Injection | 205692 | 11/15/2019 | ⤷ Try a Trial | 2033-12-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |